Decoy Therapeutics Inc. (DCOY) Balance Sheet
DCOY balance sheet, 2025
December 31, 2025 · U.S. dollars$11.1M assets = $5.2M liabilities + $5.9M equity
Both columns are drawn to the same scale: what DCOY owns equals what it owes plus shareholders’ equity. Hover a block for its value.
DCOY financial health
Descriptive bands, not a rating. Fiscal 2025.
DCOY balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $63.2M2016 | $11.1M2025 | −17.6%/yr | |
| Total liabilities | $3.9M2016 | $5.2M2025 | +3.2%/yr | |
| Shareholders’ equity | $59.3M2016 | $5.9M2025 | −22.6%/yr | |
| Cash & short-term investments | $61.1M2016 | $10.7M2025 | −17.6%/yr | |
| Total debt | $502,3322019 | $221,8662024 | −15.1%/yr | |
| Net cash (debt) | $3.2M2019 | $2.2M2024 | −$1.0M | |
| Working capital | $58.6M2016 | $5.8M2025 | −$52.8M | |
| Current ratio | 16.062016 | 2.132025 | −13.94 | |
| Debt / equity | 0.052019 | 0.152024 | +0.10 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
DCOY assets
DCOY liabilities and equity
DCOY debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
DCOY balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $10.7M | $2.4M | $5.9M | $12.1M | $29.2M | $11.1M | $3.7M | $9.8M | $33.3M | $61.1M |
| Cash & equivalents | $10.7M | $2.4M | $5.9M | $12.1M | $29.2M | $11.1M | $3.7M | $9.8M | $19.2M | $22.4M |
| Short-term investments | — | — | — | — | — | — | — | — | $14.1M | $38.7M |
| Receivables | $0 | $0 | $0 | $1.6M | $0 | $3.9M | $0 | $9,939 | $10,385 | $12,181 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $186,920 | $431,891 | $454,132 |
| Other current assets | $275,223 | $553,034 | $619,763 | $803,373 | $949,215 | $822,050 | $955,899 | $288,683 | $777,102 | $925,983 |
| Total current assets | $11.0M | $3.0M | $6.5M | $14.5M | $30.2M | $15.8M | $4.7M | $10.3M | $34.5M | $62.5M |
| Property, plant & equipment (net) | $40,559 | $0 | $0 | $0 | $7,880 | $22,639 | $25,016 | $74,000 | $331,040 | $556,315 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $8.9M | $8.9M | $8.9M | $0 | $66,399 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $30,988 | $35,412 | $66,850 | $130,501 | $1.8M | $247,113 | $308,674 | $460 | $60,196 | $191,395 |
| Total assets | $11.1M | $3.0M | $6.6M | $14.7M | $40.8M | $24.9M | $13.9M | $10.4M | $35.0M | $63.2M |
| Liabilities | ||||||||||
| Accounts payable | $940,586 | $936,994 | $602,853 | $2.9M | $1.5M | $1.9M | $1.8M | $342,530 | $2.0M | $1.2M |
| Short-term debt | — | $221,866 | $289,643 | — | — | $477,028 | $502,332 | — | — | — |
| Deferred revenue | $3.2M | — | — | — | — | — | $541,701 | $4.0M | $72,188 | $88,000 |
| Total current liabilities | $5.2M | $1.5M | $1.3M | $4.3M | $2.1M | $2.8M | $3.3M | $5.0M | $5.8M | $3.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39,214 | $8,398 |
| Total liabilities | $5.2M | $1.5M | $1.3M | $4.3M | $2.1M | $2.8M | $3.3M | $1.1M | $5.9M | $3.9M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $53 | $144 | $393 | $225 | $4,524 | $2,381 | $451 | $1,807 | $1,780 | $1,678 |
| Retained earnings (deficit) | −$94.4M | −$81.9M | −$76.3M | −$63.8M | −$32.2M | −$19.4M | −$12.1M | −$133.0M | −$111.1M | −$76.6M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | −$1,247 | −$1,614 |
| Total shareholders' equity | $5.9M | $1.5M | $5.3M | $10.4M | $38.7M | $22.2M | $10.6M | $9.3M | $29.1M | $59.3M |
| Key figures | ||||||||||
| Total debt | — | $221,866 | $289,643 | — | — | $477,028 | $502,332 | — | — | — |
| Net cash (debt) | — | $2.2M | $5.6M | — | — | $10.6M | $3.2M | — | — | — |
| Working capital | $5.8M | $1.5M | $5.2M | $10.3M | $28.1M | $13.0M | $1.4M | $5.3M | $28.7M | $58.6M |
| Tangible book value | $5.9M | $1.5M | $5.3M | $10.4M | $29.9M | $13.3M | $1.7M | $9.3M | $29.0M | $59.3M |
| Book value per share | $12.23 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 482K | — | — | — | — | — | — | — | — | — |
| Current ratio | 2.13 | 1.98 | 5.02 | 3.40 | 14.29 | 5.70 | 1.42 | 2.06 | 5.91 | 16.06 |
| Quick ratio | 2.07 | 1.61 | 4.54 | 3.22 | 13.84 | 5.40 | 1.13 | 1.96 | 5.70 | 15.71 |
| Debt / equity | — | 0.15 | 0.05 | — | — | 0.02 | 0.05 | — | — | — |
| Equity / assets | 53.3% | 50.0% | 80.3% | 70.9% | 94.8% | 88.9% | 76.2% | 89.3% | 83.2% | 93.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $8.3M | $7.8M | $10.7M | $4.8M | $794,886 | $1.8M | $2.4M | $3.3M | $3.3M | $4.4M | $5.9M | $7.6M |
| Cash & equivalents | $8.3M | $7.8M | $10.7M | $4.8M | $794,886 | $1.8M | $2.4M | $3.3M | $3.3M | $4.4M | $5.9M | $7.6M |
| Receivables | $0 | $0 | $0 | $200,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $284,200 | $537,044 | $275,223 | $1.1M | $564,692 | $506,706 | $553,034 | $538,617 | $241,068 | $457,064 | $619,763 | $743,196 |
| Total current assets | $8.6M | $8.4M | $11.0M | $6.1M | $1.4M | $2.3M | $3.0M | $3.8M | $3.5M | $4.8M | $6.5M | $8.3M |
| Property, plant & equipment (net) | $399,077 | $35,741 | $40,559 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $28,775 | $29,882 | $30,988 | $32,094 | $33,200 | $34,306 | $35,412 | $36,518 | $39,931 | $53,390 | $66,850 | $80,444 |
| Total assets | $9.0M | $8.4M | $11.1M | $6.1M | $1.4M | $2.3M | $3.0M | $3.9M | $3.6M | $4.9M | $6.6M | $8.4M |
| Liabilities | ||||||||||||
| Accounts payable | $1.3M | $936,030 | $940,586 | $1.1M | $1.5M | $1.5M | $936,994 | $165,801 | $643,051 | $713,957 | $602,853 | $1.1M |
| Short-term debt | — | — | — | — | — | $112,230 | $221,866 | $328,849 | — | $116,855 | $289,643 | $459,091 |
| Deferred revenue | $3.0M | $3.2M | $3.2M | — | — | — | — | — | — | — | — | — |
| Total current liabilities | $4.7M | $4.5M | $5.2M | $1.1M | $1.5M | $2.3M | $1.5M | $934,581 | $1.2M | $1.2M | $1.3M | $2.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $744,783 | $740,553 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $4.7M | $4.5M | $5.2M | $1.8M | $2.2M | $2.3M | $1.5M | $934,581 | $1.2M | $1.2M | $1.3M | $2.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $53 | $53 | $53 | $94 | $213 | $208 | $144 | $144 | $64 | $431 | $393 | $394 |
| Retained earnings (deficit) | −$99.0M | −$96.7M | −$94.4M | −$85.5M | −$84.6M | −$83.6M | −$81.9M | −$80.5M | −$79.5M | −$78.1M | −$76.3M | −$75.5M |
| Accumulated other comprehensive income | — | — | — | — | — | $0 | — | — | — | — | — | — |
| Total shareholders' equity | $4.3M | $3.9M | $5.9M | $4.2M | −$829,724 | $61,866 | $1.5M | $2.9M | $2.4M | $3.6M | $5.3M | $6.1M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | $112,230 | $221,866 | $328,849 | — | $116,855 | $289,643 | $459,091 |
| Net cash (debt) | — | — | — | — | — | $1.7M | $2.2M | $3.0M | — | $4.3M | $5.6M | $7.1M |
| Working capital | $3.9M | $3.8M | $5.8M | $5.0M | −$122,371 | $27,560 | $1.5M | $2.9M | $2.3M | $3.6M | $5.2M | $6.0M |
| Tangible book value | $4.3M | $3.9M | $5.9M | $4.2M | −$829,724 | $61,866 | $1.5M | $2.9M | $2.4M | $3.6M | $5.3M | $6.1M |
| Book value per share | $8.12 | $7.29 | $12.23 | $8.82 | — | — | — | — | — | — | — | — |
| Shares outstanding | 532K | 532K | 482K | 482K | — | — | — | — | — | — | — | — |
| Current ratio | 1.83 | 1.84 | 2.13 | 5.49 | 0.92 | 1.01 | 1.98 | 4.09 | 2.98 | 3.91 | 5.02 | 3.59 |
| Quick ratio | 1.77 | 1.72 | 2.07 | 4.54 | 0.54 | 0.79 | 1.61 | 3.51 | 2.78 | 3.54 | 4.54 | 3.27 |
| Debt / equity | — | — | — | — | — | 1.81 | 0.15 | 0.11 | — | 0.03 | 0.05 | 0.08 |
| Equity / assets | 48.0% | 46.0% | 53.3% | 69.7% | −59.6% | 2.6% | 50.0% | 75.8% | 66.8% | 74.7% | 80.3% | 72.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
DCOY financial position
At the end of fiscal 2025 (December 31, 2025), Decoy Therapeutics had total assets of $11.1 million (up 265.8% from a year earlier), total liabilities of $5.2 million and shareholders' equity of $5.9 million. Its current ratio was 2.13. In the latest quarter (ended June 30, 2026) total assets were $9.0 million and equity $4.3 million.
Related: DCOY income statement, DCOY cash flow statement, DCOY key metrics. See the DCOY stock overview for the latest quote and news.
DCOY balance sheet FAQ
What are Decoy Therapeutics's total assets?
Decoy Therapeutics reported total assets of $11.1 million at the end of fiscal 2025 (December 31, 2025), compared with $3.0 million a year earlier.
How much cash does Decoy Therapeutics have?
Decoy Therapeutics held $10.7 million in cash and short-term investments at the end of fiscal 2025.
What is Decoy Therapeutics's book value?
Decoy Therapeutics's shareholders' equity (book value) was $5.9 million at the end of fiscal 2025, or $12.23 per share.
What is Decoy Therapeutics's current ratio?
Decoy Therapeutics had current assets of $11.0 million and current liabilities of $5.2 million, a current ratio of 2.13 (it can cover its short-term obligations).